Tepezza (generic name Teprotumumab (generic name) is an intravenous medication prescribed by a doctor which was approved by the U.S. Food & Drug Administration (FDA) approval in January 2020 to treat of Thyroid Eye Disease (TED) which is associated with Graves’ disease. Following its approval and the wider availability there were a few patients who […]